UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Procaspase-Activating Compound-1 Synergizes with TRAIL to Induce Apoptosis in Established Granulosa Cell Tumor Cell Line (KGN) and Explanted Patient Granulosa Cell Tumor Cells In Vitro

International journal of molecular sciences, 2021-04, Vol.22 (9), p.4699

2021

Volltextzugriff (PDF)

Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinoma

Cancer letters, 2022-02, Vol.526, p.168-179

2022

Volltextzugriff (PDF)

A B1a-natural IgG-neutrophil axis is impaired in viral- and steroid-associated aspergillosis

Science translational medicine, 2022-12, Vol.14 (674), p.eabq6682

2022

Volltextzugriff (PDF)

Stroke-associated intergenic variants modulate a human FOXF2 transcriptional enhancer

Proceedings of the National Academy of Sciences - PNAS, 2022-08, Vol.119 (35), p.e2121333119

2022

Volltextzugriff (PDF)

Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti‐tumor immunity with superior safety in bladder cancer models

EMBO molecular medicine, 2017-05, Vol.9 (5), p.638-654

2017

Volltextzugriff (PDF)

High-titer manufacturing of SARS-CoV-2 Spike-pseudotyped VSV in stirred-tank bioreactors

Molecular therapy. Methods & clinical development, 2024-03, Vol.32 (1), p.101189-101189, Article 101189

2024

Volltextzugriff (PDF)

Histopathologic Analysis of Surgically Resected Lungs of Patients with Non-tuberculous Mycobacterial Lung Disease: a Retrospective and Hypothesis-generating Study

The Yale journal of biology & medicine, 2021-12, Vol.94 (4), p.527-535

2021

Volltextzugriff (PDF)

Radiation-Induced Cellular Senescence Reduces Susceptibility of Glioblastoma Cells to Oncolytic Vaccinia Virus

Cancers, 2023-06, Vol.15 (13), p.3341

2023

Volltextzugriff (PDF)

Assessment of Specificity of an Adenovirus Targeted to HER3/4

Methods in molecular biology (Clifton, N.J.), 2017, Vol.1652, p.275

2017

Volltextzugriff (PDF)

Improvement in peripheral bronchoscopy requires the use of advanced imaging

AME case reports, 2022-10, Vol.6, p.30-30

2022

Volltextzugriff (PDF)

Oncolytic Viruses in the Treatment of Bladder Cancer

Advances in urology, 2012-01, Vol.2012 (2012), p.1-11

2012

Volltextzugriff (PDF)

MP83-13 ONCOLYTIC VACCINIA VIRUS HAS SIGNIFICANT ACTIVITY AND INDUCES ANTI-TUMOR IMMUNITY IN BLADDER CANCER

The Journal of urology, 2016, Vol.195 (4), p.e1086-e1086

2016

Volltextzugriff (PDF)

Abstract 2663: CR42-24, a novel colchicine derivative, a therapeutic for bladder cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2663-2663

2018

Volltextzugriff (PDF)

Combined inhibition of autophagy with mTOR inhibitor to enhance cell death in renal cell carcinoma

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.450-450

2017

Volltextzugriff (PDF)

The role of bronchoscopy as a novel approach in preoperative lung marking for early-stage lung cancer

Translational cancer research, 2023-02, Vol.12 (2), p.221-225

2023

Volltextzugriff (PDF)

Gastrointestinal and Hepatic Disease in the Inflammatory Myopathies

Rheumatic diseases clinics of North America, 2018-02, Vol.44 (1), p.113-129

2018

Volltextzugriff (PDF)

Abstract NT-089: TRAIL-EXPRESSING ONCOLYTIC VACCINIA VIRUS COMBINED WITH SMALL-MOLECULE DRUG PAC1 IS A POTENTIALLY EFFECTIVE TREATMENT ALTERNATIVE FOR OVARIAN CANCERS

Clinical cancer research, 2019-11, Vol.25 (22_Supplement), p.NT-089-NT-089

2019

Volltextzugriff (PDF)

MP92-14 INHIBITION OF MTOR/AKT PATHWAY ENHANCES CELL DEATH VIA AUTOPHAGY IN RENAL CELL CARCINOMA

The Journal of urology, 2016-04, Vol.195 (4), p.e1167-e1167

2016

Volltextzugriff (PDF)

MP83-13 ONCOLYTIC VACCINIA VIRUS HAS SIGNIFICANT ACTIVITY AND INDUCES ANTI-TUMOR IMMUNITY IN BLADDER CANCER

The Journal of urology, 2016-04, Vol.195 (4), p.e1086-e1086

2016

Volltextzugriff (PDF)

426. Oncolytic Vaccinia Virus Has Significant Activity and Induces Anti-Tumor Immunity in Bladder Cancer

Molecular therapy, 2015-05, Vol.23, p.S168-S169

2015

Volltextzugriff (PDF)

Proteinase‐activated receptor 2‐mediated vasodilation is preserved in diabetes

The FASEB journal, 2011-04, Vol.25, p.816.19-816.19

2011

Volltextzugriff (PDF)

The Summit for Cancer Immunotherapy (Summit4CI), June 26–29, 2016 Halifax, Canada

Cancer Immunology, Immunotherapy, 2017-06, Vol.66 (6), p.811-818

2017

Volltextzugriff (PDF)

Endothelial calcium-activated potassium channels as therapeutic targets to enhance availability of nitric oxide

Canadian journal of physiology and pharmacology, 2012-06, Vol.90 (6), p.739-752

2012

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Procaspase-Activating Compound-1 Synergizes with TRAIL to Induce Apoptosis in Established Granulosa Cell Tumor Cell Line (KGN) and Explanted Patient Granulosa Cell Tumor Cells In Vitro

Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinoma

A B1a-natural IgG-neutrophil axis is impaired in viral- and steroid-associated aspergillosis

Stroke-associated intergenic variants modulate a human FOXF2 transcriptional enhancer

Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti‐tumor immunity with superior safety in bladder cancer models

Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen

High-titer manufacturing of SARS-CoV-2 Spike-pseudotyped VSV in stirred-tank bioreactors

Histopathologic Analysis of Surgically Resected Lungs of Patients with Non-tuberculous Mycobacterial Lung Disease: a Retrospective and Hypothesis-generating Study

Radiation-Induced Cellular Senescence Reduces Susceptibility of Glioblastoma Cells to Oncolytic Vaccinia Virus

Assessment of Specificity of an Adenovirus Targeted to HER3/4

Improvement in peripheral bronchoscopy requires the use of advanced imaging

Oncolytic Viruses in the Treatment of Bladder Cancer

MP83-13 ONCOLYTIC VACCINIA VIRUS HAS SIGNIFICANT ACTIVITY AND INDUCES ANTI-TUMOR IMMUNITY IN BLADDER CANCER

Abstract 2663: CR42-24, a novel colchicine derivative, a therapeutic for bladder cancer

Combined inhibition of autophagy with mTOR inhibitor to enhance cell death in renal cell carcinoma

The role of bronchoscopy as a novel approach in preoperative lung marking for early-stage lung cancer

Gastrointestinal and Hepatic Disease in the Inflammatory Myopathies

Abstract NT-089: TRAIL-EXPRESSING ONCOLYTIC VACCINIA VIRUS COMBINED WITH SMALL-MOLECULE DRUG PAC1 IS A POTENTIALLY EFFECTIVE TREATMENT ALTERNATIVE FOR OVARIAN CANCERS

MP92-14 INHIBITION OF MTOR/AKT PATHWAY ENHANCES CELL DEATH VIA AUTOPHAGY IN RENAL CELL CARCINOMA

Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection

MP83-13 ONCOLYTIC VACCINIA VIRUS HAS SIGNIFICANT ACTIVITY AND INDUCES ANTI-TUMOR IMMUNITY IN BLADDER CANCER

426. Oncolytic Vaccinia Virus Has Significant Activity and Induces Anti-Tumor Immunity in Bladder Cancer

Proteinase‐activated receptor 2‐mediated vasodilation is preserved in diabetes

The Summit for Cancer Immunotherapy (Summit4CI), June 26–29, 2016 Halifax, Canada

Endothelial calcium-activated potassium channels as therapeutic targets to enhance availability of nitric oxide

Suchergebnisse filtern